Gain Therapeutics, Inc. — Form D
Gain Therapeutics, Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-30. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-07-30
- Form: D
- Accession: 0001213900-20-019108
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Minimum investment: $50K
- Investors: 48
- Date of first sale: 2020-07-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-372084
Issuer
- Name: Gain Therapeutics, Inc.
- CIK: 0001819411
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4800 HAMPDEN LANE, BETHESDA, MD, 20814
- Phone: (301) 500-1556
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Marianne I Bjordal | Director | Bethesda, MD |
| Khalid I Islam | Director | Bethesda, MD |
| Lorenzo I Leoni | Director | Bethesda, MD |
| Eric I Richman | Director | HACKENSACK, NJ |
| Jeffrey I Riley | Director | Bethesda, MD |
| Eric I Richman | Executive Officer | HACKENSACK, NJ |
More